FDA 483 - Chandler H. Park, MD - January 15, 2021

An FDA inspection of Chandler H. Park, M.D., Clinical Investigator, revealed significant deficiencies in the conduct of a clinical trial. The firm failed to report numerous adverse events to the sponsor and maintain accurate records. Additionally, the investigation was not conducted in accordance with the investigational plan, including improper subject enrollment and missed protocol procedures.